QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$68.74 USD
-0.48 (-0.69%)
Updated Dec 4, 2023 04:00 PM ET
After-Market: $68.77 +0.03 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth B Momentum C VGM
QuidelOrtho (QDEL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$109.50 | $158.00 | $66.00 | 58.19% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for QuidelOrtho comes to $109.50. The forecasts range from a low of $66.00 to a high of $158.00. The average price target represents an increase of 58.19% from the last closing price of $69.22.
Analyst Price Targets (6 )
Broker Rating
QuidelOrtho currently has an average brokerage recommendation (ABR) of 1.83 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.83 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, three are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 50% and 16.67% of all recommendations. A month ago, Strong Buy made up 50%, while Buy represented 16.67%.
Broker Rating Breakdown

Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.83 | 1.83 | 1.83 | 1.83 | 1.83 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/17/2023 | William Blair | Andrew F Brackmann | Strong Buy | Strong Buy |
8/15/2023 | Raymond James | Andrew Cooper | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.83 |
ABR (Last week) | 1.83 |
# of Recs in ABR | 6 |
Average Target Price | $109.50 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 144 of 252 |
Current Quarter EPS Est: | 2.02 |